For people taking both semaglutide and omeprazole, there are lifestyle adjustments that can help the medications work more effectively
The takeaway: a future of brain-protective care that integrates meds, diet, sleep, exercise, and psychotherapyshifting treatment toward resilience and offering real hope for people with depression and bipolar disorder
The dual GLP-1 and GIP pathway activation in tirzepatide produces 2 to 3 percent greater visceral fat mobilization, indicating superior metabolic benefits for cardiovascular and metabolic health
GLP-1 activation slows gastric emptying
Dynamic profiling of intact glucosinolates in radish by combining UHPLC-HRMS/MS and UHPLC-QqQ-MS/MS
Retatrutide is investigational and targets GLP-1, GIP, and glucagon receptors